Show Notes
Last week, for the first time in U.S. history, federal regulators approved the sale of a birth control pill without a prescription.
Pam Belluck, a health and science correspondent for The Times, explains why, after decades of brutal battles over contraception, this decision played out so differently.
Guest: Pam Belluck, a health and science correspondent for The New York Times.
Background reading:
- The F.D.A. approved a birth control pill to be sold without a prescription for the first time in the United States, a milestone that could significantly expand access to contraception.
- Here’s how women reacted to the news.
For more information on today’s episode, visit
. Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.